Haem.io structures case findings and maps them against WHO 2022, ICC 2022 and configured ELN risk criteria, with the inputs and reasoning kept visible for clinician review.
A focused three-step criteria review workflow.
Turn case findings into a clinician-reviewable structured profile.
Report findings can be entered manually or structured for review. Mutations, cytogenetics, blast counts, and flow markers remain visible so clinicians can verify the input before criteria are applied.
Map the reviewed inputs against configured classification and risk criteria.
The interface presents WHO 2022 and ICC 2022 criteria mapping with the relevant pathway and rationale available for inspection.
Support clinician review with classification context, risk logic, and rationale.
Displays risk stratification and supporting rationale where configured. Outputs are decision support for qualified clinicians and do not replace local governance or professional judgement.
From structured findings to classification, risk context and trial review.
Enter structured findings directly, or use a report workflow to prepare key haematology findings for clinician review: mutations, VAF, cytogenetic abnormalities, blast percentage, and clinical qualifiers.
Parsed or entered values are presented in a structured summary alongside the source material. Clinicians can check and correct the data before criteria are applied.
Reviewed case data is mapped through the relevant WHO 2022 and ICC 2022 criteria. The interface shows the resulting pathway and the rules applied.
WHO 2022 and ICC 2022 classification outputs are displayed side by side for clinician review, with the associated reasoning steps.
Where configured, Haem.io applies ELN 2022 and ELN 2024 risk logic. The category is shown with its calculation steps and supporting context.
Based on classification context, genetics, and case profile, Haem.io can surface potentially relevant clinical trials for review. Each match shows eligibility signals and what additional data is needed to confirm suitability.
Selected feedback shared with Haem.io.
“Haem.io has the potential to transform diagnosis and decision making for patients with haematological malignancies across the NHS.”
“Haem.io has the potential to revolutionise the quality of care that patients receive.”
“A real step forward in what technology can offer in supporting clinicians to make accurate clinical diagnoses.”
“I would wholeheartedly recommend this platform. This will be of significant use for clinicians in the front line.”
The interactive classifier is available to try without creating an account.